Jagsonpal Pharmaceuticals Designates Key Personnel as Senior Management
Jagsonpal Pharmaceuticals Limited has designated two senior professionals into its management structure following an internal restructuring move. The changes are effective from July 29, 2026.The company has appointed Mr. Balmukund Keshav and Mr. Sanjay Singhal to key roles within the organization. Mr. Balmukund Keshav will serve as Deputy General Manager (Information Technology), while Mr. Sanjay Singhal is designated as General Manager (CQA & Regulatory Affairs).
Profile of New Senior Management Personnel
The appointments bring together extensive experience in both IT leadership and pharmaceutical operations. The details regarding the designated personnel, including their background and tenure, are summarized below:| Particulars | Mr. Balmukund Keshav | Mr. Sanjay Singhal |
|---|---|---|
| Designation | Deputy General Manager - Information Technology | General Manager (CQA & Regulatory Affairs) |
| Effective Date | July 29, 2026 | July 29, 2026 |
| Brief Profile | Holds an MBA in Information Systems from Sikkim Manipal University and a B.Sc. (Chemistry Hons.) from Magadh University. He has over 29 years of experience in IT leadership. | A Pharmacy professional with Masters Degree in Pharmaceutical science from Birla Institute of Technical studies, Pilani (BITS PILANI). He possesses 31 years' experience in the pharmaceutical industry. |
| Company Tenure | Has been associated with Jagsonpal Pharmaceuticals Ltd for 17 years. During this tenure, he has managed digital transformation, ERP implementation, ITGC audits, and enterprise infrastructure management. | Has been associated with the Company since March 11, 2020. Mr. Singhal is also a Government approved technical person for all dosage forms across manufacturing and analytical divisions. |
The company notes that Mr. Balmukund Keshav's expertise covers IT governance, risk and information security, vendor management, and digital process automation. For Mr. Sanjay Singhal, the professional background includes comprehensive expertise across manufacturing, supply chain, Quality and regulatory affairs within the pharmaceutical sector.
JAGSNPHARM Stock Price Movement
Today, Jagsonpal Pharmaceuticals Limited shares edged higher by 2.20% on a positive close for the day, settling at ₹230.5. The equity saw trading activity involving 77,095 shares throughout the market session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.